Depending on the developmental stage of a product, the company's portfolio of other products, whether the company is held publicly or privately, and a variety of other factors, there are a range of options for financing the commercialization of a product and the growth of the company itself. The panel includes senior executives of companies with innovative financing and a principal of a leading health-care private equity fund that has invested more than $1 billion in pharmaceutical companies over the past five years.



Objectives:

Discuss strategies for financing later-stage pharmaceutical products using debt, equity and royalty streams.

Discuss new financing sources and finance technologies for funding later-stage products.

Discuss the factors in making financing decisions.